Americas · Regional markets · BNN Bloomberg
Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive Q3 results
Pfizer raised its full-year profit and revenue forecasts on Tuesday as strong demand for its recently acquired cancer drug Padcev and blockbuster blood thinner Eliquis led to…
Read the full article on BNN Bloomberg Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bnnbloomberg.ca)



